Primary Immunodeficiency Diseases Consortium Conference

描述（由申请人提供）：该补助金要求为出席2009年原发性免疫缺陷疾病联合会会议的演讲者提供旅行赠款金。这笔赠款将提供资金，以支持与会者的旅行，并协助计划的发展。将向制药和生物技术公司寻求额外资金。该计划与USIDNET共同组织，计划在临床免疫学会联合会（FOCIS）年会之前举行。该计划将在临床免疫学会（CIS），FOCIS，美国过敏，哮喘和免疫学会（AAAAI），欧洲免疫缺陷学会（ESID）和USIDNET的网站上进行广告。除了在其网站上公布这些信息外，他们还将向其成员发出通知，为联合会做广告。这项活动的目的是接触国际目标受众，包括受训研究员、初级教员以及该领域的知名专家。该联盟计划将该领域的专家聚集在一起，讨论最近的更新以及与我们对各种原发性免疫缺陷症影响的科学过程的理解有关的材料。通过研讨会期间的讲座和网络，临床医生和研究人员将获得对原发性免疫缺陷的更好的知识。这些材料将主要以讲座形式提供，但也将有海报会议和预定的休息时间，以便与最先进的讲师进行网络、指导和一对一的时间。本次会议的目标是继续推进对这些复杂疾病的诊断，分子缺陷，并发症和治疗的理解;发展学术医学这一领域的新科学家的职业生涯;提高对临床免疫学及其在科学发现和临床应用中的重要性的认识;并促进不同医学中心和国家的研究者之间，以及新研究者和该领域有经验的医生-科学家之间的未来合作。原发性免疫缺陷疾病联盟会议的使命是汇集来自世界各地的专家，讨论在任何一个机构都不常见的疾病的诊断，发病机制和管理。重点将放在对原发性免疫缺陷的理解的最新进展。拟议的原发性免疫缺陷疾病联盟会议将汇集该领域的专家，讨论最新的更新以及与我们对各种原发性免疫缺陷影响的科学过程的理解有关的材料。这次研讨会将提高该领域的医生和基础研究人员的知识，但最终将导致改善病人护理。

DESCRIPTION (provided by applicant): This grant requests support for travel grants to be provided to presenters for attending the 2009 Primary Immunodeficiency Diseases Consortium Conference. This grant will provide funding to support travel for the participants and assist with program development. Additional funding will be solicited from pharmaceutical and biotechnology companies. This program, which is co-organized with the USIDNET, is scheduled to take place just prior to the Federation of Clinical Immunology Societies (FOCIS) Annual Meeting. The program will be advertised on websites from the Clinical Immunology Society (CIS), FOCIS, the American Academy of Allergy, Asthma & Immunology (AAAAI), the European Society of Immunodeficiency (ESID), and the USIDNET. In addition to posting this information on their web sites, they will also send out notices to their membership advertising the Consortium. This activity is intended to reach an international target audience consisting of fellows-in-training, junior faculty, as well as noted experts in the field. This Consortium plans to bring together experts in the field to discuss recent updates as well as material related to our understanding of the scientific processes affected in various primary immunodeficiencies. Both by lecture and networking during the symposium, clinicians and researchers will come away with an improved knowledge of primary immunodeficiencies. The material will be delivered primarily in lecture format, but there will also be a poster session and scheduled breaks to allow networking, mentoring, and one-on-one time with the state-of-the art lecturers. The objectives for this conference are to continue to advance understanding of the diagnosis, molecular defects, complications, and treatment of these complex diseases; to develop the careers of new scientists in this area of academic medicine; to enhance awareness of clinical immunology and its importance in scientific discoveries and clinical applications; and to stimulate future collaborations between investigators in different medical centers and countries, and between new investigators and experienced physician-scientists in the field. The mission of the Primary Immunodeficiency Diseases Consortium Conference is to bring together experts from around the world to discuss diagnosis, pathogenesis, and management of diseases which are often uncommon at any one institution. The emphasis will be on recent advances in the understanding of primary immunodeficiencies. The proposed Primary Immunodeficiency Diseases Consortium Conference will bring together experts in the field to discuss recent updates as well as material related to our understanding of the scientific processes affected in various primary immunodeficiencies. This symposium will enhance knowledge of physicians and basic researchers in the field but will ultimately lead to improved patient care.